These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 29512413

  • 1. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
    Hyun JW, Huh SY, Shin HJ, Woodhall M, Kim SH, Irani SR, Lee SH, Waters P, Kim HJ.
    Mult Scler; 2019 Apr; 25(4):585-590. PubMed ID: 29512413
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
    Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Wuerfel J, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Callegaro D, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira A, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C, Ruggieri S, Amato MP, Ulivelli M, Groppa S, Grothe M, Llufriu S, Sepulveda M, Lukas C, Bellenberg B, Schneider R, Sowa P, Celius EG, Proebstel AK, Yaldizli Ö, Müller J, Stankoff B, Bodini B, Carmisciano L, Sormani MP, Barkhof F, De Stefano N, Ciccarelli O, MAGNIMS Study Group.
    Brain; 2023 Jun 01; 146(6):2489-2501. PubMed ID: 36515653
    [Abstract] [Full Text] [Related]

  • 9. Development and validation of a simple and practical method for differentiating MS from other neuroinflammatory disorders based on lesion distribution on brain MRI.
    Patel J, Pires A, Derman A, Fatterpekar G, Charlson RE, Oh C, Kister I.
    J Clin Neurosci; 2022 Jul 01; 101():32-36. PubMed ID: 35525154
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.
    Yang L, Li H, Xia W, Quan C, Zhou L, Geng D, Li Y.
    Eur Radiol; 2020 Mar 01; 30(3):1470-1479. PubMed ID: 31748853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS.
    Etemadifar M, Salari M, Etemadifar MR, Sabeti F, Fateh ST, Aminzade Z.
    Mult Scler Relat Disord; 2022 Apr 01; 60():103664. PubMed ID: 35219242
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease.
    Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ, Syc-Mazurek SB, Redenbaugh V, Lopez-Chiriboga AS, Valencia-Sanchez C, Hemingway C, Tillema JM, Ciccarelli O, Pittock SJ, Hacohen Y, Flanagan EP.
    Neurology; 2024 May 28; 102(10):e209303. PubMed ID: 38710000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.